Английская Википедия:Bermekimab

Материал из Онлайн справочника
Перейти к навигацииПерейти к поиску

Шаблон:Short description Шаблон:Drugbox

Bermekimab[1] (MABp1, trade name Xilonix) is a human monoclonal antibody of IgG1k isotype targeting Interleukin 1 alpha (IL1A).[2] Шаблон:As of, bermekimab is in phase III clinical trials as an immunotherapy for colorectal cancer[3] and as of September 2018 in phase II clinical trials for the treatment of atopic dermatitis.[4]

Bermekimab is being developed by XBiotech Inc.[5]

References

Шаблон:Reflist

Шаблон:Monoclonals for immune system Шаблон:Antineoplastic-drug-stub